Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose - PubMed (original) (raw)
Comparative Study
Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose
Patricia H Janak et al. Alcohol. 2003 May.
Abstract
Behavioral effects of ethanol are mediated by actions at multiple neurotransmitter receptors and signaling systems; prominent among these is the type A gamma-aminobutyric acid (GABA(A)) receptor. Previous work has shown that the GABAergic neuroactive steroid allopregnanolone enhances ethanol-reinforced instrumental responding in rat. In the current study, we compared the effects of allopregnanolone with the direct GABA(A) agonist muscimol and the direct type B GABA (GABA(B)) agonist baclofen in male Long-Evans rats lever pressing for a 10% ethanol solution in a limited-access procedure. The effects of concurrently available sucrose were also tested to determine the selectivity of these drugs for altering ethanol self-administration when an alternate reinforcer was available. In Experiment 1, we found that presession systemic administration of both muscimol (0.3 and 1 mg/kg) and baclofen (1 and 3 mg/kg) reduced responding for ethanol. In contrast, allopregnanolone (3 and 5.6 mg/kg) enhanced responding for ethanol. In Experiment 2, we found that a 1-mg/kg dose of baclofen reduced responding for ethanol, but not for sucrose, whereas both baclofen and muscimol, administered at a higher dose of 3 mg/kg, decreased both ethanol- and sucrose-reinforced responding. Allopregnanolone, at a dose of 5.6 mg/kg, but not of 3 mg/kg, selectively increased ethanol-reinforced responding, indicating a less robust effect of allopregnanolone on responding within the concurrent reinforcement procedure than that observed when ethanol alone was available. The results support the suggestion that direct agonist action at either the GABA(A) or the GABA(B) receptor decreases ethanol self-administration. Muscimol produces a nonselective decrease in instrumental responding, whereas baclofen may selectively reduce ethanol intake at lower doses, but not higher ones, possibly limiting its potential use for treatment of alcohol abuse in human beings. In contrast, allopregnanolone can selectively enhance ethanol self-administration in the presence of a concurrently available alternate reinforcer, indicating that the direct GABA(A) agonist muscimol and the allosteric GABA(A) modulator allopregnanolone do not produce similar behavioral effects on instrumental responding for ethanol reinforcement.
Similar articles
- Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats.
Maccioni P, Serra S, Vacca G, Orrù A, Pes D, Agabio R, Addolorato G, Carai MA, Gessa GL, Colombo G. Maccioni P, et al. Alcohol. 2005 Jul;36(3):161-8. doi: 10.1016/j.alcohol.2005.08.003. Alcohol. 2005. PMID: 16377457 - Benzodiazepine-GABA modulation of concurrent ethanol and sucrose reinforcement in the rat.
Petry NM. Petry NM. Exp Clin Psychopharmacol. 1997 Aug;5(3):183-94. Exp Clin Psychopharmacol. 1997. PMID: 9260066 - The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats.
Walker BM, Koob GF. Walker BM, et al. Alcohol Clin Exp Res. 2007 Jan;31(1):11-8. doi: 10.1111/j.1530-0277.2006.00259.x. Alcohol Clin Exp Res. 2007. PMID: 17207096 Free PMC article. - Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors.
Finn DA, Beckley EH, Kaufman KR, Ford MM. Finn DA, et al. Horm Behav. 2010 Jan;57(1):12-22. doi: 10.1016/j.yhbeh.2009.07.002. Epub 2009 Jul 15. Horm Behav. 2010. PMID: 19615369 Free PMC article. Review.
Cited by
- GABAB Receptors and Alcohol Use Disorders: Preclinical Studies.
Holtyn AF, Weerts EM. Holtyn AF, et al. Curr Top Behav Neurosci. 2022;52:157-194. doi: 10.1007/7854_2020_178. Curr Top Behav Neurosci. 2022. PMID: 32808090 - Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking.
Weiland A, Garcia S, Knackstedt LA. Weiland A, et al. Front Pharmacol. 2015 Mar 10;6:44. doi: 10.3389/fphar.2015.00044. eCollection 2015. Front Pharmacol. 2015. PMID: 25805996 Free PMC article. - Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts.
Lenz B, Schöpp E, Müller CP, Bleich S, Hillemacher T, Kornhuber J. Lenz B, et al. Psychopharmacology (Berl). 2012 Dec;224(3):421-9. doi: 10.1007/s00213-012-2770-5. Epub 2012 Jun 17. Psychopharmacology (Berl). 2012. PMID: 22707254 - Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: potential role of endogenous neurosteroids?
Ford MM, Nickel JD, Finn DA. Ford MM, et al. Alcohol. 2005 Aug;37(1):23-33. doi: 10.1016/j.alcohol.2005.11.002. Alcohol. 2005. PMID: 16472716 Free PMC article. - Inhibition of 5alpha-reduced steroid biosynthesis impedes acquisition of ethanol drinking in male C57BL/6J mice.
Ford MM, Yoneyama N, Strong MN, Fretwell A, Tanchuck M, Finn DA. Ford MM, et al. Alcohol Clin Exp Res. 2008 Aug;32(8):1408-16. doi: 10.1111/j.1530-0277.2008.00718.x. Epub 2008 Jun 28. Alcohol Clin Exp Res. 2008. PMID: 18565155 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical